BSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.
Senores Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,215.00
- Market cap
- ₹5,596 Cr
- Revenue (annual)
- ₹632.6 Cr
- Net profit (annual)
- ₹115.4 Cr
- P/E (TTM)
- 41.9×Sector 46.1×
- Promoter holding
- 45.82%+0.00% QoQ
- FII holding
- 6.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senores Pharmaceuticals Ltd
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Senores Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.
Senores Pharmaceuticals Results Update
Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.
Other annual general meeting announcements
All →Globe Multi Ventures Annual General Meeting
Globe Multi Ventures filed proceedings of its 41st AGM held on October 29, 2026. E-voting results will follow after the scrutinizer's report.
Amco India Annual General Meeting
Amco India Ltd filed certified minutes of its 39th AGM held 30 September 2026 via VC/OAVM. Minutes record routine ordinary business, including adoption of FY2026 financial statements and director re-appointment.
Bodhi Tree Multimedia Annual General Meeting
Bodhi Tree Multimedia shareholders passed a special resolution at the 1st EOGM on 28 October 2026 approving a QIP. Votes in favour were 100% of votes polled.
Uniinfo Telecom Services Annual General Meeting
Uniinfo Telecom filed minutes of its 16th AGM held 30 September 2026. The meeting covered accounts, a director's re-appointment, auditor appointment and an independent director's appointment.
BF Utilities Annual General Meeting
BF Utilities will hold its 26th Annual General Meeting on 28 November 2026 via video conferencing. The filing is an intimation of the AGM date with notice and annual report to follow.
Paramount Cosmetics (I) Annual General Meeting
Paramount Cosmetics held its first EGM on 29 October 2026, seeking approval to increase authorised share capital. Voting results will follow after the scrutinizer's report.